Author Details
Rozenshtraukh, L V
| Issue | Section | Title | File |
| Vol 87, No 1 (2015) | Editorial article | Refralon (niferidil) is a new class III antiarrhythmic agent for pharmacological cardioversion for persistent atrial fibrillation and atrial flutter |
|
Address of the Editorial Office:
Correspondence address:
|
Managing Editor:
|
© 2018-2021 "Consilium Medicum" Publishing house | |